Skip to Content

A176 150 (Fluvoxamine Maleate Extended-Release 150 mg)

Pill with imprint A176 150 is Purple / White, Capsule-shape and has been identified as Fluvoxamine maleate extended-release 150 mg. It is supplied by Par Pharmaceutical Inc..

Fluvoxamine is used in the treatment of obsessive compulsive disorder; anxiety and stress; social anxiety disorder; depression; body dysmorphic disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy. Fluvoxamine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A176 150

Fluvoxamine maleate extended-release

Imprint:
A176 150
Strength:
150 mg
Color:
Purple / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective serotonin reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical Inc.
National Drug Code (NDC):
10370-0176

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide